|
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
|
Nov 2013
|
Fu B
|
myelodysplastic syndromes (MDS)
|
|
Standardizing the Initial Evaluation for Myelodysplastic Syndromes.
|
Nov 2013
|
Curr Hematol
|
myelodysplastic syndromes (MDS)
|
|
Acquired aplastic anemia in children
|
Oct 2013
|
Pediatr Clin North Am
|
aplastic anemia
|
|
The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
|
Oct 2013
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure.
|
Oct 2013
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Laboratory tests for paroxysmal nocturnal hemoglobinuria (PNH).
|
Oct 2013
|
Am J Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic syndromes: toward a risk-adapted treatment approach.
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
|
Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
|
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.
|
Oct 2013
|
Am J Hematol
|
aplastic anemia
|
|
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.
|
Oct 2013
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
